JP2008538099A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008538099A5 JP2008538099A5 JP2007554173A JP2007554173A JP2008538099A5 JP 2008538099 A5 JP2008538099 A5 JP 2008538099A5 JP 2007554173 A JP2007554173 A JP 2007554173A JP 2007554173 A JP2007554173 A JP 2007554173A JP 2008538099 A5 JP2008538099 A5 JP 2008538099A5
- Authority
- JP
- Japan
- Prior art keywords
- dione
- cancer
- propyl
- substituted
- purine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 0 *C1=NN(*)c2nc(N(*)C(N(*)C3=O)=O)c3[n]2C1 Chemical compound *C1=NN(*)c2nc(N(*)C(N(*)C3=O)=O)c3[n]2C1 0.000 description 3
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US64972605P | 2005-02-02 | 2005-02-02 | |
| US11/344,295 US7435740B2 (en) | 2005-02-02 | 2006-01-31 | Adenosine A3 receptor modulators |
| PCT/US2006/003477 WO2006083916A2 (en) | 2005-02-02 | 2006-02-01 | Novel adenosine a3 receptor modulators |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008538099A JP2008538099A (ja) | 2008-10-09 |
| JP2008538099A5 true JP2008538099A5 (https=) | 2008-12-18 |
Family
ID=36777854
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007554173A Withdrawn JP2008538099A (ja) | 2005-02-02 | 2006-02-01 | 新規なアデノシンａ３受容体調節剤 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7435740B2 (https=) |
| EP (1) | EP1845993A4 (https=) |
| JP (1) | JP2008538099A (https=) |
| KR (1) | KR20070100331A (https=) |
| AU (1) | AU2006210817B2 (https=) |
| BR (1) | BRPI0606750A2 (https=) |
| CA (1) | CA2596612A1 (https=) |
| IL (1) | IL184532A0 (https=) |
| MX (1) | MX2007008501A (https=) |
| NZ (1) | NZ556649A (https=) |
| WO (1) | WO2006083916A2 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090088403A1 (en) * | 2007-05-07 | 2009-04-02 | Randy Blakely | A3 adenosine receptors as targets for the modulation of central serotonergic signaling |
| WO2009092602A2 (en) * | 2008-01-24 | 2009-07-30 | Universität Zürich | Anti-angiogenic compounds |
| JP2011528363A (ja) * | 2008-07-16 | 2011-11-17 | キング・ファーマシューティカルズ・リサーチ・アンド・デベロプメント・インコーポレイティッド | アテローム性動脈硬化症の治療 |
| WO2011010306A1 (en) | 2009-07-21 | 2011-01-27 | Ramot At Tel-Aviv University Ltd. | A3 adenosine receptor ligands for modulation of pigmentation |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6586429B2 (en) * | 2000-11-29 | 2003-07-01 | Cell Therapeutics, Inc. | Tricyclic fused xanthine compounds and their uses |
-
2006
- 2006-01-31 US US11/344,295 patent/US7435740B2/en not_active Expired - Fee Related
- 2006-02-01 MX MX2007008501A patent/MX2007008501A/es active IP Right Grant
- 2006-02-01 WO PCT/US2006/003477 patent/WO2006083916A2/en not_active Ceased
- 2006-02-01 JP JP2007554173A patent/JP2008538099A/ja not_active Withdrawn
- 2006-02-01 KR KR1020077017126A patent/KR20070100331A/ko not_active Ceased
- 2006-02-01 AU AU2006210817A patent/AU2006210817B2/en not_active Ceased
- 2006-02-01 BR BRPI0606750-6A patent/BRPI0606750A2/pt not_active IP Right Cessation
- 2006-02-01 NZ NZ556649A patent/NZ556649A/en not_active IP Right Cessation
- 2006-02-01 CA CA002596612A patent/CA2596612A1/en not_active Abandoned
- 2006-02-01 EP EP06734138A patent/EP1845993A4/en not_active Withdrawn
-
2007
- 2007-07-10 IL IL184532A patent/IL184532A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9974777B2 (en) | Tetrahydrocarboline derivative | |
| JP2011057693A5 (https=) | ||
| EP3210969B1 (en) | Kcnq2-5 channel activator | |
| JP2006507220A5 (https=) | ||
| EA017714B1 (ru) | Модуляторы tgr5 и способы их применения | |
| WO2015183794A1 (en) | Tgr5 agonist complexes for treating diabetes and cancer | |
| WO2007139150A1 (ja) | ＴＮＦα阻害物質を含有してなる抗インフルエンザウイルス剤 | |
| US20220073516A1 (en) | Crystalline spirocyclic compound, a dosage form containing, a method for using in treatment of disease, and a method for recrystallizing | |
| JPWO2018117177A1 (ja) | Ｂｒｋ阻害化合物 | |
| JP2006503850A5 (https=) | ||
| JP2014533264A (ja) | 三環式化合物、それらを含む組成物およびそれらの使用 | |
| JP2013129632A (ja) | Ｅｎｐｐ２阻害化合物 | |
| JP2011518168A5 (https=) | ||
| JP2010540649A5 (https=) | ||
| US20080027094A1 (en) | Tropane Compounds and Pharmaceutical Compositions Comprising the Same as an Active Ingredient | |
| US11566002B2 (en) | Substituted tetrahydrocyclopenta[C]pyrroles, substituted dihydropyrrolizines, analogues thereof, and methods using same | |
| JP7746165B2 (ja) | Ｎｕｒｒ１受容体調節因子 | |
| JP2008538099A5 (https=) | ||
| JP2013503908A5 (https=) | ||
| WO2007086554A1 (ja) | トロパン化合物およびそれらを有効成分として含有する医薬組成物 | |
| CN1533273A (zh) | 紫杉烷类药物的节拍式给药 | |
| RU2007111754A (ru) | Применение мидостаурина для лечения желудочно-кишечных стромальных опухолей | |
| CN106946851B (zh) | 一种用于预防和治疗肾结石的药物 | |
| TW202114709A (zh) | 具有吡咯并嘧啶骨架之新穎碳酸酯化合物或其藥學上可容許之鹽 | |
| JPWO2023177592A5 (https=) |